CCS
Century Communities, Inc.
CCS trails on the overall score without a compensating advantage in the available component scores.
F
Ford Motor Company
F has the edge over CCS overall, supported by stronger valuation and stronger modeled upside.
CCS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Stable |
CCS's profitability and balance sheet are currently stable, but its revenue and cash flow are under pressure.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
CCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.2x | $15.75 | -70% |
| Fair | 8x | $29.98 | -42% |
| Expensive | 11x | $39.91 | -23% |
| Current | 14x | $51.92 | — |
| Forward | 27x | $51.92 | — |
Historical ranges are pointers, not guarantees.
CCS's PE is in its expensive range at 14x. Analysts expect earnings to fall, which would put today's price at 27x next year's earnings.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
CCS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect CCS's earnings and profitability to decline, with its revenue holding steady.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
F has the edge over CCS on the outlook, with more favorable earnings and profitability expectations.
CCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.89 | -50% |
| Q3 2026 | $3.75 | -45% |
| Q2 2026 | $4.56 | -44% |
| Q1 2026 | $4.44 | -54% |
| Q4 2025 | $4.86 | -53% |
| Q3 2025 | $6.85 | -32% |
| Q2 2025 | $8.19 | -18% |
| Q1 2025 | $9.66 | +7.2% |
| Q4 2024 | $10.40 | +29% |
CCS has the edge over F on earnings quality, reporting a profit while its opponent remains loss making.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
CCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $864.5M | -12% |
| Q2 2026 | $927.2M | -7.3% |
| Q1 2026 | $789.7M | -13% |
| Q4 2025 | $1.2B | -3.1% |
| Q3 2025 | $980.3M | -14% |
| Q2 2025 | $1B | -3.7% |
| Q1 2025 | $903.2M | -4.8% |
| Q4 2024 | $1.3B | +5.6% |
CCS's revenue has slid since its 2024 peak: $864M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.8% | -3 points |
| Q2 2026 | 5.3% | +0.6 points |
| Q1 2026 | 4.2% | -1.6 points |
| Q4 2025 | 3.8% | -6.8 points |
| Q3 2025 | 4.9% | -4.8 points |
| Q2 2025 | 4.7% | -5.9 points |
| Q1 2025 | 5.8% | -3.1 points |
| Q4 2024 | 11% | +0.2 points |
CCS's operating margin was 1.8% last quarter, down 3 points from the same quarter a year ago, near the bottom of its range since 2019.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F has the edge over CCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over CCS on profitability, with a higher operating margin.
CCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$142.4M | -$121.6M |
| Q2 2026 | -$89.6M | -$72.1M |
| Q1 2026 | -$57.1M | -$17.1M |
| Q4 2025 | $202.6M | -30% |
| Q3 2025 | -$20.8M | +$81.1M |
| Q2 2025 | -$17.6M | +$100.1M |
| Q1 2025 | -$40M | -355% |
| Q4 2024 | $290.6M | +$310.6M |
CCS has burned cash in six of the last eight quarters: −$87M over the past year, against $212M the year before.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F has the edge over CCS on cash generation, producing positive trailing cash flow while its opponent burns cash.
CCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -177K shares |
| 1 year | -5.1% | -1.5M shares |
| 3 years | -12% | -3.8M shares |
| 5 years | -17% | -6M shares |
| Available history | -8.7% | -2.7M shares |
CCS has the edge over F on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $11.6M |
| Q2 2026 | $19.6M |
| Q1 2026 | $40M |
| Q4 2025 | $20M |
| Q3 2025 | $20M |
| Q2 2025 | $48M |
| Q1 2025 | $55.6M |
| Q4 2024 | $30.7M |
CCS spent $91M buying back its own shares over the past year, down 41% from the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has 4.1B diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
CCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | -0.0x | Net Cash |
CCS's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago.
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has the edge over CCS on leverage, with a lower net debt burden relative to earnings.
CCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 12.1 | Oversold |
CCS's weekly RSI is 39 (neutral) and its Stochastic is 12 (oversold).
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
CCS PE vs Consumer Cyclical Sector
| Metric | CCS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 23% below |
| PE % | 95 | 47 | 48 pts above |
CCS is trading at 14x earnings, a 23% discount to the Consumer Cyclical sector's median of 18x.
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
CCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.3 | 7.8% below |
| 20 week MA | $62.7 | 17% below |
| 50 week MA | $61.8 | 16% below |
| 100 week MA | $62.7 | 17% below |
| 200 week MA | $70.9 | 27% below |
CCS is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
F is in a downtrend: it's below all five of its weekly moving averages, and 1.4% below its 200-week average.
CCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $47.5 | +74% |
| 2021 | $47.5 | $79.5 | +67% |
| 2022 | $79.5 | $51.4 | -35% |
| 2023 | $51.4 | $91.1 | +77% |
| 2024 | $91.1 | $73.6 | -19% |
| 2025 | $73.6 | $59.0 | -20% |
| 2026 YTD | $59.0 | $51.9 | -12% |
CCS has finished lower in three of the last six years. It's down 12% so far in 2026.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over CCS on returns for 2026, with the stronger performance.